Laboratorios Farmaceuticos ROVI (ROVI)

Madrid
Currency in EUR
Disclaimer
56.700
+0.550(+0.98%)
Closed
Trading near 52-week High
Day's Range
56.00056.800
52 wk Range
35.20056.800
Bid/Ask
51.00 / 56.85
Prev. Close
56.15
Open
56.6
Day's Range
56-56.8
52 wk Range
35.2-56.8
Volume
79,190
Average Volume (3m)
102,230
1-Year Change
53%
Shares Outstanding
53,369,709
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
62.350
Upside +9.965%

People Also Watch

14.340
IDR
+1.34%
4.110
CABK
-0.46%
10.220
ACX
+1.49%
1.023
UNI
+0.39%
14.180
REP
+1.00%
How do you feel today about ROVI?
Vote to see community's results!
or

Laboratorios Farmaceuticos ROVI Company Profile

Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.

Employees
1993
Market
Spain